John Pappajohn, Director, 10% Owner at CANCER GENETICS, INC (CGIX), bought 150,000 shares at $1.86 ($279K) on 2017-12-08, disclosed to the SEC on 2017-12-11.
Open-market purchase of $279k CGIX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CGIX | BUY | 2019-02-01 | $230K | — | Filing → |
| CGIX | BUY | 2019-01-16 | $230K | — | Filing → |
| MYND | BUY | 2018-08-28 | $163K | — | Filing → |